IL150774A0 - Apoptin-associating protein - Google Patents

Apoptin-associating protein

Info

Publication number
IL150774A0
IL150774A0 IL15077401A IL15077401A IL150774A0 IL 150774 A0 IL150774 A0 IL 150774A0 IL 15077401 A IL15077401 A IL 15077401A IL 15077401 A IL15077401 A IL 15077401A IL 150774 A0 IL150774 A0 IL 150774A0
Authority
IL
Israel
Prior art keywords
apoptin
associating protein
associating
protein
Prior art date
Application number
IL15077401A
Other languages
English (en)
Original Assignee
Leadd Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00200169A external-priority patent/EP1120463A1/fr
Application filed by Leadd Bv filed Critical Leadd Bv
Publication of IL150774A0 publication Critical patent/IL150774A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15077401A 2000-01-17 2001-01-17 Apoptin-associating protein IL150774A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200169A EP1120463A1 (fr) 2000-01-17 2000-01-17 Protéine associée à l'apoptine
EP00250118 2000-04-07
PCT/NL2001/000030 WO2001053351A2 (fr) 2000-01-17 2001-01-17 Proteine s'associant a l'apoptine

Publications (1)

Publication Number Publication Date
IL150774A0 true IL150774A0 (en) 2003-02-12

Family

ID=26071746

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15077401A IL150774A0 (en) 2000-01-17 2001-01-17 Apoptin-associating protein

Country Status (6)

Country Link
US (1) US6809189B2 (fr)
JP (1) JP2003520593A (fr)
AU (1) AU3422801A (fr)
CA (1) CA2397571A1 (fr)
IL (1) IL150774A0 (fr)
WO (1) WO2001053351A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016165A2 (fr) 1999-09-02 2001-03-08 Leadd B.V. Proteine a association d'apoptine
WO2001042461A2 (fr) * 1999-12-10 2001-06-14 Leadd B.V. Proteine associee a l'apoptine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249774T3 (es) * 1994-12-22 2006-04-01 Novartis Ag Proteinas serina/tronina quinasas nucleares.
EP0927757A1 (fr) * 1997-12-03 1999-07-07 Leadd B.V. Méthodes et moyens pour induire l'apoptose par interférence avec des protéines similaires à Bip
EP0921192A1 (fr) * 1997-12-03 1999-06-09 Leadd B.V. Molecules interagissant avec l'apoptine
EP0924296A3 (fr) 1997-12-03 2001-08-01 Leadd B.V. Méthode et moyens d' induction de l'apoptose par interférence du traitement d'ARN
DE19817557A1 (de) * 1998-04-09 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe

Also Published As

Publication number Publication date
CA2397571A1 (fr) 2001-07-26
WO2001053351A2 (fr) 2001-07-26
US20020127553A1 (en) 2002-09-12
AU3422801A (en) 2001-07-31
WO2001053351A3 (fr) 2001-12-06
US6809189B2 (en) 2004-10-26
JP2003520593A (ja) 2003-07-08

Similar Documents

Publication Publication Date Title
GB0001704D0 (en) Protein
GB0003079D0 (en) Novel protein
GB0011185D0 (en) Protein
GB0024446D0 (en) Protein
GB0027905D0 (en) New protein
GB0009181D0 (en) Protein
GB0025677D0 (en) New protein
IL150774A0 (en) Apoptin-associating protein
EP1323734A4 (fr) Proteine de liaison a l'irap
EP1179592A4 (fr) Proteines du type nectine 3
GB0008549D0 (en) Protein
GB0020345D0 (en) Protein
GB0001700D0 (en) Novel protein
GB0030186D0 (en) Protein
GB0008774D0 (en) Protein
GB0001709D0 (en) Protein
GB0001708D0 (en) Protein
GB0011056D0 (en) Protein
GB0030294D0 (en) Protein
GB0031341D0 (en) Protein
GB0014825D0 (en) Protein
GB0015307D0 (en) Protein
GB0027308D0 (en) Drug-activated proteins
GB0014158D0 (en) New protein
GB0010596D0 (en) New protein